Aclimostat

N/A

Report date: 2024/02/22 20:00:41

NME

Base Information

Drug NameAclimostat

Drug Alias NameZGN-1061

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMethionine aminopeptidase 2 inhibitors

TargetsMethionine aminopeptidase 2

Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew ZealandAustralia

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesZafgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesZafgen Inc

Active IndicationsN/A

Inactive IndicationsOverweightObesityDiabetes Mellitus, Type 2

ATC CodeN/A